FDA Approved: TERAZOSIN — Supplemental Application (Bionpharma Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Terazosin from Bionpharma Inc., marking an update to the product's approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Hypertension

Drugs mentioned

• Terazosin (terazosin)

Snippet

SUPPL AP for TERAZOSIN (TERAZOSIN)